2026/2027 | MSCP Study Guide & Practice
Questions | Menopause & Midlife Women’s
Health, Hormone Therapy, Vasomotor
Symptoms, GSM & Bone Health
NAMS MENOPAUSE CERTIFICATION EXAM 2026/2027 | MSCP STUDY GUIDE &
PRACTICE QUESTIONS
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
OVERVIEW
• This comprehensive study guide contains carefully crafted multiple-choice
questions designed to assess and reinforce your knowledge of menopause and
midlife women's health across all major clinical domains including hormonal
physiology, vasomotor symptoms, hormone therapy options, genitourinary
changes, and bone health management.
• Use this material to identify knowledge gaps, practice clinical decision-making in
real-world scenarios, and build confidence before sitting for the NAMS MSCP
certification examination by systematically working through questions, reviewing
detailed rationales, and cross-referencing key concepts with current NAMS
guidelines.
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
━━━━━━━━━━━━━━━━━━━━━━━━━━━━
SECTION 1: GENERAL MENOPAUSE PHYSIOLOGY & DEFINITIONS
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
━━━━━━━━━━━━━━━━━━━━━━━━━━━━
1. Which of the following best defines menopause?
A) The period of declining ovarian function lasting 5-8 years before the final
menstrual period
B) Twelve consecutive months of amenorrhea following the final menstrual period
C) The entire lifespan phase from the onset of irregular menstruation until death
,D) The time when a woman experiences her first hot flash or night sweat
E) A pathological condition requiring immediate medical intervention
CORRECT ANSWER: B - Twelve consecutive months of amenorrhea following
the final menstrual period
RATIONALE: Menopause is defined clinically as the final menstrual period,
confirmed retrospectively after 12 consecutive months without menstruation. This
is the standard definition endorsed by NAMS and the World Health Organization.
Options A, C, and D describe perimenopause or associated symptoms rather than
menopause itself. Option E is incorrect as menopause is a normal biological
transition, not a pathological condition.
2. What is the average age at which menopause occurs in North American
women?
A) 48 years
B) 50 years
C) 52 years
D) 55 years
E) 58 years
CORRECT ANSWER: C - 52 years
RATIONALE: The mean age of menopause in North American women is
approximately 51-52 years, with a range of approximately 40-60 years. Most
women reach menopause between ages 48-55 years. The average age has
remained relatively stable over the past several decades. Factors such as smoking,
genetics, and ovarian reserve can influence the timing of menopause, but 52 years
represents the population average.
3. Perimenopause is characterized by which of the following hormonal
patterns?
,A) Consistently elevated follicle-stimulating hormone with stable estradiol
B) Variable estradiol levels with elevated and variable follicle-stimulating hormone
C) Progressively declining estradiol with suppressed follicle-stimulating hormone
D) Stable estradiol and follicle-stimulating hormone with increased progesterone
E) Elevated estradiol with suppressed follicle-stimulating hormone
CORRECT ANSWER: B - Variable estradiol levels with elevated and variable
follicle-stimulating hormone
RATIONALE: During perimenopause, the hallmark hormonal pattern is erratic
ovulation leading to variable estradiol levels accompanied by elevated and
fluctuating FSH levels. As ovarian follicles become depleted and ovulation becomes
sporadic, FSH rises in an attempt to stimulate follicle development. These hormonal
fluctuations explain the irregular menstrual cycles and variable vasomotor
symptoms experienced during this transition. Single measurements of FSH or
estradiol during perimenopause are not reliable for confirming menopausal status.
4. Which of the following is considered early menopause?
A) Menopause occurring before age 40
B) Menopause occurring between ages 40-45
C) Menopause occurring between ages 45-50
D) Menopause occurring between ages 50-55
E) Menopause occurring after age 55
CORRECT ANSWER: A - Menopause occurring before age 40
RATIONALE: Early menopause (also called premature ovarian failure or premature
ovarian insufficiency when presenting with symptoms) is defined as menopause
occurring before age 40. This occurs in approximately 1% of women. Menopause
occurring between ages 40-45 is sometimes termed "early menopause" but
technically falls within the broader range of natural menopause timing. Women
with early menopause warrant investigation for underlying causes such as
, autoimmune conditions, genetic predispositions, prior chemotherapy or radiation,
or chromosomal abnormalities.
5. What is the primary endocrinological change that initiates the menopausal
transition?
A) Sudden drop in hypothalamic gonadotropin-releasing hormone production
B) Progressive depletion of ovarian follicles below the threshold needed for
sustained ovulation
C) Acute suppression of pituitary function
D) Increased production of inhibin A and B
E) Decreased metabolism of estrogen by the liver
CORRECT ANSWER: B - Progressive depletion of ovarian follicles below the
threshold needed for sustained ovulation
RATIONALE: The fundamental cause of menopause is the depletion of the ovarian
follicle pool to approximately 1,000 or fewer follicles (compared to 1-2 million at
birth). This progressive decline in follicular reserve occurs at an accelerated rate
after age 35-37. When the follicle count drops below the threshold needed for
estrogen production and ovulation, menopause ensues. The hypothalamus and
pituitary respond to this change by increasing GnRH and FSH, but the ovaries can
no longer respond adequately. This is fundamentally an ovarian problem, not a
central nervous system problem.
6. Which hormone remains relatively stable after menopause, even as
estradiol levels decline dramatically?
A) Progesterone
B) Testosterone
C) Androstenedione
D) Dehydroepiandrosterone (DHEA)